Szu‐Hsien Wu

2.1k citations
70 papers · 1.6k indexed · h-index 23
Topics
Mesenchymal stem cell research (9 papers)Glutathione Transferases and Polymorphisms (8 papers)Genomics, phytochemicals, and oxidative stress (7 papers)
Partner nations
TaiwanUnited StatesJapan

In The Last Decade

Szu‐Hsien Wu

66 papers receiving 1.5k citations

Peers

Szu‐Hsien Wu
Comparison fields: 5 of 152
  • Molecular Biology 568
  • Oncology 292
  • Surgery 270
  • Genetics 180
  • Cancer Research 168
Replace Qinglin Li with:
Qinglin Li China
Dennis Ma Canada
Joanne T. M. Tan Australia
Shih‐Ming Huang Taiwan
Pablo Álvarez Spain
Ying He China
Ming Hu China
Bo Yu China
Mi Ra Kim South Korea
Szu‐Hsien Wu relative to Qinglin Li China Qinglin Li's profile →
Citations per field
00.5×1.5×
Qinglin Li · 1×
Citations per year

Countries citing papers authored by Szu‐Hsien Wu

Since Specialization
Citations

This map shows the geographic impact of Szu‐Hsien Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szu‐Hsien Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szu‐Hsien Wu more than expected).

Fields of papers citing papers by Szu‐Hsien Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szu‐Hsien Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szu‐Hsien Wu. The network helps show where Szu‐Hsien Wu may publish in the future.

Co-authorship network of co-authors of Szu‐Hsien Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Szu‐Hsien Wu. A scholar is included among the top collaborators of Szu‐Hsien Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szu‐Hsien Wu. Szu‐Hsien Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 3
3 8
4 0
5 7
6 1
7 5
8 10
9 22
10
Combining Multiple Rupture Models in Real-Time for Earthquake Early Warning
1
11 4
12 6
13 22
14 60
15 9
16 19
17 42
18 15
19 135
20 101

About Szu‐Hsien Wu

Szu‐Hsien Wu is a scholar working on Rehabilitation, Genetics and Biochemistry, having authored 70 papers that have together received 1.6k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (9 papers), Glutathione Transferases and Polymorphisms (8 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). The work is most often cited by research in Genetics (180 citations), Rehabilitation (113 citations) and Cancer Research (168 citations). Szu‐Hsien Wu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Li‐Yu Tsai, Shih‐Meng Tsai, Hsu Ma, Ming‐Feng Hou, Linda A. Hou, Jyh‐Chong Liang, Koji Kanayama, Ming‐Jung Liu, Shu‐Hsing Wu and Kotaro Yoshimura. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026